Urothelial Bladder Cancer
📧 Sign up to get email alerts when something new happens for Urothelial Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy [Phase 2]
This Phase 2 trial from Institut Claudius Regaud is recruiting metastatic urothelial bladder cancer patients who have not progressed after f…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib [Phase 2]
Phase 2 trial update evaluating multiorgan metabolic imaging response assessment of abemaciclib.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations [Phase 3]
Phase 3 trial of oral infigratinib as adjuvant treatment for invasive urothelial carcinoma with FGFR3 alterations has been terminated; resul…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Study of Tremelimumab in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial update for tremelimumab in advanced solid tumors completed with posted results in 2019.